News And Updates

09.09.2021

Centrus Energy Corp. to Present at Lake Street’s 5th Annual Best Ideas Growth (BIG5) Conference September 14-15, 2021

Centrus Energy, supplier of nuclear fuel components and services for the nuclear power industry that is also conducting a High-Assay, Low-Enriched Uranium (HALEU) enrichment demonstration program for the U.S. Department of Energy, announced that Daniel B. Poneman, President and Chief Executive Officer, and Philip Strawbridge, Chief Financial Officer, are scheduled to present at the Lake Street 5th Annual Best Ideas Growth (BIG5) Conference.

News Releases

08.11.2021

Centrus Reports Second Quarter 2021 Results

Centrus Energy Corp. today reported net income of $11.6 million for the quarter ended June 30, 2021, compared to net income of $33.7 million for the second quarter of 2020.

News Releases

08.09.2021

Centrus to Webcast Conference Call on August 12 at 8:30 a.m. ET

Centrus Energy Corp. will broadcast its quarterly conference call with shareholders and the financial community over the Internet on Thursday, August 12, 2021, at 8:30 a.m. ET. The Company will release its second quarter earnings report for 2021, which ended June 30, 2021, after the close of markets on Wednesday, August 11.

News Releases

06.16.2021

Centrus Energy Corp. Reports Results of Annual Stockholder Meeting and Announces Extension of Section 382 Rights Agreement

BETHESDA, Md. – Centrus Energy Corp. announced the results of its 2021 annual meeting of stockholders held on June 16, 2021. As of April 19, 2021, the meeting’s record date, there were 12,918,602 shares of the Company’s Class A common stock outstanding, each entitled to one vote, and approximately 79.8 percent of those shares were represented at the annual meeting.

News Releases

06.14.2021

NRC Approves Centrus Energy’s License Amendment for HALEU Production

Centrus Energy Corp. announced that the U.S. Nuclear Regulatory Commission (NRC) approved the Company’s license amendment request to produce High-Assay, Low-Enriched Uranium (HALEU) at the Piketon, Ohio, enrichment facility. The Piketon plant is now the only U.S. facility licensed to enrich uranium up to 20 percent Uranium-235 (U-235) and expects to begin demonstrating HALEU production early next year. 

News Releases

05.17.2021

Centrus Announces New Sales Commitments Valued At $225 Million

BETHESDA, Md. – Centrus Energy Corp. announced today that it has secured new nuclear fuel sales contracts and commitments valued at approximately $225 million over the past 12 months. 

News Releases

05.11.2021

Centrus Reports First Quarter 2021 Results

BETHESDA, Md. – Centrus Energy Corp. today reported net income of $5.1 million for the quarter ended March 31, 2021, compared to a net income of $11.3 million for the first quarter of 2020.

News Releases

05.07.2021

Centrus to Webcast Conference Call on May 12 at 8:30 a.m. ET

Centrus Energy Corp. will broadcast its quarterly conference call with shareholders and the financial community over the Internet on Wednesday, May 12, 2021, at 8:30 a.m. ET.

News Releases

03.23.2021

Centrus Provides Update on Construction of America’s First HALEU Production Facility

BETHESDA, Md. - Centrus Energy Corp. (NYSE American: LEU) is providing an update on construction of the nation’s first production facility for High-Assay, Low-Enriched Uranium (HALEU) in Piketon, Ohio.  “Despite the impact of the pandemic and the extraordinary steps we have taken to protect our workforce – including limiting the number of people who can be on the construction site at any one time – we have kept construction on track and expect to begin producing HALEU by  next year,” said Centrus President and CEO Daniel B. Poneman.  “We believe this first-of-a-kind facility can play a critical role in meeting both government and commercial requirements for HALEU, powering America’s nuclear leadership as the world turns to a new generation of advanced reactors and advanced nuclear fuels.”

News Releases

03.18.2021

Centrus Energy Corp. Reports Financial Results for the Fourth Quarter and Full Year 2020

“Despite the unprecedented health crisis posed by COVID-19, with a large portion of our staff shifting to telework, Centrus has had a great year that saw us return to profitability, improve our balance sheet, and deliver value to stockholders with a higher share price,” said Daniel Poneman, Centrus President and Chief Executive Officer. “Our technical solutions team continues to make strong progress on the High-Assay, Low-Enriched Uranium (HALEU) program and we expect to begin demonstrating production of HALEU by early next year. Our sales team also secured over $100 million in new commitments from November through the end of January.”

News Releases